Adult T-cell leukemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
{{SI}}
{{SI}}
{{CMG}}; {{AE}} {{RT}}
{{CMG}}; {{AE}} {{RT}}
{{SK}} T-cell leukaemia, adult


==Overview==
==Overview==

Revision as of 04:15, 5 August 2012

Adult T-cell leukemia
Adult T cell leukemia: Blood smear from a patient from the Kyushu region of Japan with HTLV-1-positive adult T-cell leukemia. The lymphocyte has a markedly lobulated, "flower" shaped nucleus. (Wright-Giemsa stain)
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology
ICD-10 C83-C88
ICD-9 204.0-208.9
ICD-O: Template:ICDO
DiseasesDB 29486
MeSH D015460

WikiDoc Resources for Adult T-cell leukemia

Articles

Most recent articles on Adult T-cell leukemia

Most cited articles on Adult T-cell leukemia

Review articles on Adult T-cell leukemia

Articles on Adult T-cell leukemia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adult T-cell leukemia

Images of Adult T-cell leukemia

Photos of Adult T-cell leukemia

Podcasts & MP3s on Adult T-cell leukemia

Videos on Adult T-cell leukemia

Evidence Based Medicine

Cochrane Collaboration on Adult T-cell leukemia

Bandolier on Adult T-cell leukemia

TRIP on Adult T-cell leukemia

Clinical Trials

Ongoing Trials on Adult T-cell leukemia at Clinical Trials.gov

Trial results on Adult T-cell leukemia

Clinical Trials on Adult T-cell leukemia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adult T-cell leukemia

NICE Guidance on Adult T-cell leukemia

NHS PRODIGY Guidance

FDA on Adult T-cell leukemia

CDC on Adult T-cell leukemia

Books

Books on Adult T-cell leukemia

News

Adult T-cell leukemia in the news

Be alerted to news on Adult T-cell leukemia

News trends on Adult T-cell leukemia

Commentary

Blogs on Adult T-cell leukemia

Definitions

Definitions of Adult T-cell leukemia

Patient Resources / Community

Patient resources on Adult T-cell leukemia

Discussion groups on Adult T-cell leukemia

Patient Handouts on Adult T-cell leukemia

Directions to Hospitals Treating Adult T-cell leukemia

Risk calculators and risk factors for Adult T-cell leukemia

Healthcare Provider Resources

Symptoms of Adult T-cell leukemia

Causes & Risk Factors for Adult T-cell leukemia

Diagnostic studies for Adult T-cell leukemia

Treatment of Adult T-cell leukemia

Continuing Medical Education (CME)

CME Programs on Adult T-cell leukemia

International

Adult T-cell leukemia en Espanol

Adult T-cell leukemia en Francais

Business

Adult T-cell leukemia in the Marketplace

Patents on Adult T-cell leukemia

Experimental / Informatics

List of terms related to Adult T-cell leukemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Synonyms and keywords: T-cell leukaemia, adult

Overview

Human T cell leukemia/lymphotropic virus type 1 (HTLV-1) is believed to be the cause of several diseases, including adult T cell leukemia/lymphoma (ATLL), a rare cancer of the immune system's own T-cells.

Pathophysiology

ATLL is usually a highly aggressive non-Hodgkin's lymphoma with no characteristic histologic appearance except for a diffuse pattern and a mature T-cell phenotype. Circulating lymphocytes with an irregular nuclear contour (leukemic cells) are frequently seen. Several lines of evidence suggest that HTLV-1 causes ATLL. This evidence includes the frequent isolation of HTLV-1 from patients with this disease and the detection of HTLV-1 proviral genome in ATLL leukemic cells. ATLL is frequently accompanied by visceral involvement, hypercalcemia, lytic bone lesions, and skin lesions. Most patients die within one year of diagnosis.

Transmission

Transmission of HTLV-1 is believed to occur from mother to child; by sexual contact; and through exposure to contaminated blood, either through blood transfusion or sharing of contaminated needles.

Infection with HTLV-1, like infection with other retroviruses, probably occurs for life and can be inferred when antibody against HTLV-1 is detected in the serum.

Epidemiology and Demographics

Prevalence

HTLV-1 infection in the United States appears to be rare. Although little serologic data exist, prevalence of infection is thought to be highest among blacks living in the Southeast. A prevalence rate of 30% has been found among black intravenous drug abusers in New Jersey, and a rate of 49% has been found in a similar group in New Orleans. It is possible that prevalence of infection is increasing in this risk group. Studies of HTLV-1 antibody indicate that the virus is endemic in southern Japan, in the Caribbean, and in Africa.

Incidence

ATLL is relatively uncommon among those infected with HTLV-1. The overall incidence of ATLL is estimated at about 66 per 100,000 adult HTLV-1 carriers per year.

Race

Those cases that have been reported have occurred mostly among persons from the Caribbean or blacks from the Southeast (National Institutes of Health, unpublished data). There appears to be a long latent period between HTLV-1 infection and the start of ATLL.


External links

  • Franchini G, Nicot C, Johnson JM (2003). "Seizing of T cells by human T-cell leukemia/lymphoma virus type 1". Adv. Cancer Res. 89: 69–132. PMID 14587871.

References


Template:WikiDoc Sources